1. Takiyama, H.: Supersaturation operation for quality control op crystalline particles in solution crystallization. Advanced Powder Tech. 23, 273–278 (2012)
2. Slavin, P.A., Sheen, D.B., Shepherd, E.E.A., Sherwood, J.N., Feederb, N., Docherty, R., Milojevic, S.: Morphological evaluation of the γ-polymorph of indomethacin. J. Crystal Growth. 237–239, 300–305 (2002)
3. Morissette, S.L., Almarsson, O., Peterson, M.L., Remenar, J.F., Read, M.J., Lemmo, A.V., Ellis, S., Cima, M.J., Gardner, C.R.: High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Delivery Rev., 56, 275–300 (2004)
4. Singhal, D., Curatolo, W.: Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Deliv. Rev. 56, 335–347 (2004)
5. Takiyama, H., Minamisono, T., Osada, Y., Matsuoka, M.: Operation design for controlling polymorphism in the anti-solvent crystallization by using ternary phase diagram. Chem. Eng. Res. Des. 88, 1242–1247 (2010)